Latest Forum Topics /
Riverstone
Last:0.895
![]() |
![]() |
Riverstone go go go!
|
|||||
Godwinlow
Elite |
14-Feb-2022 18:25
|
||||
x 0
x 0 Alert Admin |
Next Covid strain could kill many more, warn scientists ahead of England restrictions endingRobin McKie Science editor and Michael Savage Policy editor
Sun, 13 February 2022, 3:10 AM· 4-min read
 
Photograph: John Sibley/ReutersDemands grow for government science chiefs to reveal evidence backing move to lift last protective measures   ADVERTISEMENT
 
A future variant of Covid-19 could be much more dangerous and cause far higher numbers of deaths and cases of serious illness than Omicron, leading UK scientists have warned. As a result, many of them say that caution needs to be taken in lifting the last Covid restrictions in England, as Boris Johnson plans to do next week. At the same time, demands are growing for Chris Whitty and Patrick Vallance, the government&rsquo s most senior advisers on Covid, to hold a press conference to reveal what evidence there was to back the decision to end all pandemic restrictions. The dangers posed by accepting the widespread assumption that Covid-19 variants would continue to get milder in their impact was highlighted by epidemiologist Prof Mark Woolhouse, of Edinburgh University.  
&ldquo The Omicron variant did not come from the Delta variant. It came from a completely different part of the virus&rsquo s family tree. And since we don&rsquo t know where in the virus&rsquo s family tree a new variant is going to come from, we cannot know how pathogenic it might be. It could be less pathogenic but it could, just as easily, be more pathogenic,&rdquo he said. This point was backed by virologist Prof Lawrence Young of Warwick University. &ldquo People seem to think there has been a linear evolution of the virus from Alpha to Beta to Delta to Omicron,&rdquo he told the  Observer. &ldquo But that is simply not the case. The idea that virus variants will continue to get milder is wrong. A new one could turn out to be even more pathogenic than the Delta variant, for example.&rdquo David Nabarro, a special envoy on Covid-19 for the World Health Organization, also highlighted the uncertainty of how future variants might behave: &ldquo There will be more variants after Omicron and if they are more transmissible they will dominate. In addition, they may cause different patterns of illness, in other words they may turn out to be more lethal or have more long-term consequences.&rdquo Nabarro urged authorities to continue to plan for the possibility that there will be surges in numbers of people who are ill and need hospital care. &ldquo It would be prudent to encourage people to protect themselves and others consistently. An approach that does not do this would be a gamble with potentially severe consequences. I cannot see any upsides to such a gamble. The pandemic has a long way to go and &ndash as is the case since it started &ndash people and their leaders will influence its long-term impact through actions they take now.&rdquo The warnings came as charities and teachers called for England&rsquo s chief medical officer and chief scientific adviser to offer a public explanation of the plan, unveiled in parliament last week, to  lift all Covid restrictions  &ndash including the requirement to isolate after testing positive &ndash in England from Thursday 24 February. The call comes as new figures suggest that people with blood cancer are now accounting for a higher proportion of Covid deaths than at any point in the pandemic. According to analysis by the Office for National Statistics, a total of 458 people with blood cancer in England and Wales died of Covid between October and December 2021 &ndash one in 20 of those who died of Covid during that time. People with blood cancer have weakened immune systems and so are less likely to be protected by vaccines. &ldquo The lack of any joined-up plan to support the immunocompromised suggests that they have not featured prominently in the government&rsquo s decision to lift the remaining Covid restrictions,&rdquo said Gemma Peters, chief executive of Blood Cancer UK. &ldquo We understand we cannot keep restrictions for ever, but given the potential negative impact for immunocompromised people, it is important that the government&rsquo s advisers set out the scientific basis.&rdquo Related:  &lsquo I&rsquo m deeply concerned&rsquo : workers on plans to end all Covid rules in England Fiona Loud, policy director of Kidney Care UK, urged the government to show commitment to the nation&rsquo s 500,000 immunosuppressed people by sharing their plans, and evidence for their decision-making: &ldquo Abandoning all measures without preventive treatments, free testing, and a duty not to expose immunosuppressed people to Covid-19 unnecessarily risks making us into second-class citizens.&rdquo Robin Bevan, headteacher of Southend high school for boys, said last week&rsquo s announcement felt premature: &ldquo It would be much more reassuring &ndash and also be much easier to explain to parents and to pupils &ndash if there was a narrative rooted in science rather than a narrative rooted in libertarian aspiration.&rdquo Ceinwen Giles, who has reduced immunity after cancer treatment, said Johnson&rsquo s announcement left her feeling excluded. &ldquo There seems to be the perception that somehow immunocompromised people are very old and very sick and it doesn&rsquo t really matter. If you are old and sick, you still matter. This just means we&rsquo re being shut out.&rdquo A government spokesperson said: &ldquo Those considered clinically extremely vulnerable are advised to follow the same guidance as the general public, but consider taking extra precautions to reduce their chance of catching Covid-19. Vaccines are the best way we can protect ourselves from the virus.&rdquo |
||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
14-Feb-2022 13:10
|
||||
x 0
x 0 Alert Admin |
Price may go up after result announcement also
|
||||
Useful To Me Not Useful To Me | |||||
|
|||||
marco69
Senior |
14-Feb-2022 13:09
|
||||
x 0
x 0 Alert Admin |
Agree. It could drop from 95c after result. Be cautious
|
||||
Useful To Me Not Useful To Me | |||||
Checkerman
Master |
14-Feb-2022 12:57
|
||||
x 0
x 0 Alert Admin |
better dun anyhow give advice price may fall after reuslt announcement
|
||||
Useful To Me Not Useful To Me | |||||
marco69
Senior |
14-Feb-2022 12:56
|
||||
x 0
x 0 Alert Admin |
Been observe a while. Looks like Riverstone already performing away from the healthcare peer. So far many times don't follow the peer trend movement. | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
easywin
Supreme |
14-Feb-2022 10:37
|
||||
x 0
x 0 Alert Admin |
Is clearly profitable company, 74/75 is very good entering price.    | ||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
14-Feb-2022 10:09
|
||||
x 0
x 0 Alert Admin |
If 4q make 266m , fy will be1569m. Dividend will be more than 0.40.
|
||||
Useful To Me Not Useful To Me | |||||
Midtermer
Master |
14-Feb-2022 10:05
|
||||
x 0
x 0 Alert Admin |
Based on ug results, I expect RS NP to be at least comparable QoQ so the dividend payout may be even higher than expected. Cheers.
|
||||
Useful To Me Not Useful To Me | |||||
|
|||||
aspasp
Senior |
14-Feb-2022 07:11
|
||||
x 0
x 0 Alert Admin |
Is ug latest result considered good ?
|
||||
Useful To Me Not Useful To Me | |||||
desmodeus
Veteran |
14-Feb-2022 00:26
|
||||
x 0
x 0 Alert Admin |
promising if ughealth results anything to go by
|
||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
13-Feb-2022 20:50
|
||||
x 0
x 0 Alert Admin |
Hope drop to below 0.70 , so that can buy and keep long term for dividebds
|
||||
Useful To Me Not Useful To Me | |||||
marco69
Senior |
13-Feb-2022 12:20
|
||||
x 0
x 0 Alert Admin |
Comparing with other glove stocks, RS at least have hugher chance to "maintain" the profit as their cleanroom product command higher profit margin and highet asp. Let see then.
If expect good dividend, near the date could see fluctuations as those trader try ro play with sentiment. Will hv multiple ups n downs I expected. |
||||
Useful To Me Not Useful To Me | |||||
|
|||||
aspasp
Senior |
13-Feb-2022 11:34
|
||||
x 0
x 0 Alert Admin |
If pull back is good opportunity to accumulate for coming fatty dividend
|
||||
Useful To Me Not Useful To Me | |||||
marco69
Senior |
11-Feb-2022 11:52
|
||||
x 0
x 0 Alert Admin |
Usually when someone say something like this, it will not hold well. It's not you, just that I observe... 😅
|
||||
Useful To Me Not Useful To Me | |||||
Richardlai
Master |
11-Feb-2022 09:38
|
||||
x 0
x 0 Alert Admin |
Riverstone holding well on its own ..... compared to other glove stocks ! Good  | ||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
09-Feb-2022 22:37
|
||||
x 0
x 0 Alert Admin |
So 40sens is highly possible
|
||||
Useful To Me Not Useful To Me | |||||
marco69
Senior |
09-Feb-2022 22:17
|
||||
x 0
x 0 Alert Admin |
Indeed. Look like they generate alot of profit from cleanroom product. Profit margin also high from that segment. Base on current shortage of chip and manufacturers ramping up production to meet demand. ASP for cleanroom gloves will still be high.
Based on that, chance of NP higher than 1450m is high.
|
||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
09-Feb-2022 21:04
|
||||
x 0
x 0 Alert Admin |
Note : np of 1450m is very conservative , should be higher because first 9 months already made more tham 1300.m
|
||||
Useful To Me Not Useful To Me | |||||
aspasp
Senior |
09-Feb-2022 20:52
|
||||
x 0
x 0 Alert Admin |
Believe fy np should be around RM 1,450m./1,482m shares . Eps will be 97.84 sens. 50% will be 48.9 sens less 10 sens interim dividend . So final will be 38.9 sen
|
||||
Useful To Me Not Useful To Me | |||||
marco69
Senior |
09-Feb-2022 20:31
|
||||
x 0
x 0 Alert Admin |
That's about 13c sgd. Try to be conservative but if their dividend payout policy still stand, looks like it going to be that much. Almost 18% gain from current price.
|
||||
Useful To Me Not Useful To Me |